Insider Transactions in Q1 2020 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.61%
|
$309,288
$28.37 P/Share
|
|
Mar 27
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-18.26%
|
$280,000
$28.37 P/Share
|
|
Mar 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$125,000
$25.81 P/Share
|
|
Mar 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$135,000
$27.76 P/Share
|
|
Mar 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
21,658
-0.57%
|
$628,082
$29.13 P/Share
|
|
Mar 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,537
-0.05%
|
$102,573
$29.13 P/Share
|
|
Mar 20
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-15.44%
|
$290,000
$29.13 P/Share
|
|
Mar 18
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
15,281
-73.21%
|
$473,711
$31.41 P/Share
|
|
Mar 18
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,281
+50.0%
|
$183,372
$12.21 P/Share
|
|
Mar 17
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
16,317
-83.25%
|
$505,827
$31.65 P/Share
|
|
Mar 17
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,317
+50.0%
|
$195,804
$12.21 P/Share
|
|
Mar 16
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-0.4%
|
$520,000
$26.17 P/Share
|
|
Mar 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
4,676
-0.07%
|
-
|
|
Mar 13
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.39%
|
$231,966
$21.52 P/Share
|
|
Mar 13
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-13.37%
|
$230,000
$23.0 P/Share
|
|
Mar 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
4,990
-0.06%
|
$104,790
$21.77 P/Share
|
|
Mar 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.08%
|
$115,000
$23.42 P/Share
|
|
Mar 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
12,351
-0.07%
|
$308,775
$25.71 P/Share
|
|
Mar 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,117
-0.06%
|
$102,925
$25.71 P/Share
|
|
Mar 09
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
104
-100.0%
|
$3,120
$30.0 P/Share
|
|
Mar 09
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104
+50.0%
|
$1,248
$12.21 P/Share
|
|
Mar 09
2020
|
Jennifer Ling Lee Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
361
-7.55%
|
$9,747
$27.33 P/Share
|
|
Mar 06
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.77%
|
$309,288
$28.77 P/Share
|
|
Mar 06
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.8%
|
$270,000
$27.98 P/Share
|
|
Mar 04
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.56%
|
$540,000
$27.71 P/Share
|
|
Mar 02
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
3,001
-100.0%
|
$90,030
$30.12 P/Share
|
|
Mar 02
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,001
+50.0%
|
$36,012
$12.21 P/Share
|
|
Mar 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,570
-0.07%
|
$312,390
$27.09 P/Share
|
|
Mar 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,857
-0.06%
|
$104,139
$27.09 P/Share
|
|
Feb 28
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-10.55%
|
$230,000
$23.38 P/Share
|
|
Feb 28
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.38%
|
$265,104
$24.07 P/Share
|
|
Feb 27
2020
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
8,006
-62.25%
|
$264,198
$33.48 P/Share
|
|
Feb 27
2020
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,006
+50.0%
|
$96,072
$12.21 P/Share
|
|
Feb 26
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,652
-0.48%
|
$522,256
$28.74 P/Share
|
|
Feb 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,286
-0.08%
|
$121,578
$23.0 P/Share
|
|
Feb 25
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,348
-0.05%
|
$33,700
$25.87 P/Share
|
|
Feb 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.48%
|
$180,000
$18.67 P/Share
|
|
Feb 21
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.54%
|
$180,000
$18.47 P/Share
|
|
Feb 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.49%
|
$198,828
$18.16 P/Share
|
|
Feb 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
5,286
-0.03%
|
$95,148
$18.86 P/Share
|
|
Feb 18
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
5,000
-0.07%
|
-
|
|
Feb 14
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.47%
|
$209,874
$19.02 P/Share
|
|
Feb 14
2020
|
Paul Sagan Director |
BUY
Open market or private purchase
|
Indirect |
52,631
+11.13%
|
$999,989
$19.0 P/Share
|
|
Feb 13
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.24%
|
$95,000
$19.23 P/Share
|
|
Feb 12
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.24%
|
$95,000
$19.44 P/Share
|
|
Feb 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
12,909
-0.08%
|
$296,907
$23.5 P/Share
|
|
Feb 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,303
-0.06%
|
$98,969
$23.5 P/Share
|
|
Feb 07
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.48%
|
$231,966
$21.81 P/Share
|
|
Feb 07
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,876
-0.07%
|
$112,148
$23.0 P/Share
|
|
Feb 07
2020
|
Lorence H. Kim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
33,295
-2.49%
|
$765,785
$23.06 P/Share
|